The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia
A Farrokhi, T Atre, J Rever, M Fidanza, W Duey… - Leukemia, 2024 - nature.com
The presence of supernumerary chromosomes is the only abnormality shared by all patients
diagnosed with high-hyperdiploid B cell acute lymphoblastic leukemia (HD-ALL). Despite …
diagnosed with high-hyperdiploid B cell acute lymphoblastic leukemia (HD-ALL). Despite …
Polyploidy in Cancer: causal mechanisms, cancer-specific consequences, and emerging treatments
PJ Conway, J Dao, D Kovalskyy, D Mahadevan… - Molecular cancer …, 2024 - AACR
Drug resistance is the major determinant for metastatic disease and fatalities, across all
cancers. Depending on the tissue of origin and the therapeutic course, a variety of biological …
cancers. Depending on the tissue of origin and the therapeutic course, a variety of biological …
Identification, characterization and biological studies of kinesine spindle protein inhibitor, benzo [b][1, 4] oxazine-6-carboxamide derivative, via 3D-pharmacophore …
SA Elseginy - Journal of Molecular Structure, 2024 - Elsevier
Kinesin spindle protein (Eg5) has been widely studied, as an important target for developing
chemotherapy drugs, due to its essential role in mitotic spindle formation in mitosis. In this …
chemotherapy drugs, due to its essential role in mitotic spindle formation in mitosis. In this …
Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification
C Zhang, B Wu, YF Wu, C di Ciano-Oliveira… - bioRxiv, 2024 - biorxiv.org
Centrosome amplification (CA), an abnormal increase in the number of centrosomes in the
cell, is a recurrent phenomenon in lung and other malignancies. Although CA contributes to …
cell, is a recurrent phenomenon in lung and other malignancies. Although CA contributes to …
Use of a TPX2 Small Molecule Inhibitor to Prevent Chemotherapy Induced Polyploidy
PJ Conway 3rd - 2024 - search.proquest.com
Chemotherapy induced polyploidy is a mechanism of inherited drug resistance resulting in
an aggressive disease course in cancer patients. Alisertib, an Aurora Kinase A ATP site …
an aggressive disease course in cancer patients. Alisertib, an Aurora Kinase A ATP site …